Beckwith - Wiedemann syndrome: Multiple molecular mechanisms

Expert Reviews in Molecular Medicine

Volumn 8, Issue 17, 2006, Pages 1-19

  Enklaar, Thorsten ^a   Zabel, Bernhard U ^a   Prawitt, Dirk ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1C; POTASSIUM CHANNEL KCNQ1; UNCLASSIFIED DRUG;

ABDOMINAL WALL DEFECT; BECKWITH WIEDEMANN SYNDROME; CHROMOSOME 11P; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPIGENETICS; FAMILIAL DISEASE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GIGANTISM; HUMAN; MACROGLOSSIA; MOLECULAR GENETICS; NEPHROBLASTOMA; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; BECKWITH-WIEDEMANN SYNDROME; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DNA METHYLATION; EPIGENESIS, GENETIC; GENOMIC IMPRINTING; GENOTYPE; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; MUTATION; PHENOTYPE; TRANSCRIPTION, GENETIC;

EID: 33748157127     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399406000020     Document Type: Review

References (98)

1. Wiedemann, H.R. (1969) [The EMG-syndrome: Exomphalos, macroglossia, gigantism and disturbed carbohydrate metabolism]. Z Kinderheilkd 106, 171-185
2. Pettenati, M.J. et al. (1986) Wiedemann-Beckwith syndrome: Presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum Genet 74, 143-154
3. Thorburn, M.J. et al. (1970) Exomphalos-macroglossia-gigantism syndrome in Jamaican infants. Am J Dis Child 119, 316-321
4. Cooper, W.N. et al. (2005) Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 13, 1025-1032
5. Baujat, G. et al. (2004) Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome. Am J Hum Genet 74, 715-720
6. Redeker, E. et al. (1994) An integrated physical map of 210 markers assigned to the short arm of human chromosome 11. Genomics 21, 538-550
7. Alders, M. et al. (2000) Disruption of a novel imprinted zinc-finger gene, ZNF215, in Beckwith-Wiedemann syndrome. Am J Hum Genet 66, 1473-1484
8. Hoovers, J.M. et al. (1995) Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc Natl Acad Sci U S A 92, 12456-12460
9. Shows, T.B. et al. (1996) Report of the Fifth International Workshop on Human Chromosome 11 Mapping 1996. Cytogenet Cell Genet 74, 1-56
10. Weksberg, R. et al. (2003) Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet 12 Spec No 1, R61-68
11. Henry, I. et al. (1991) Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 351, 665-667
12. Rainier, S. et al. (1993) Relaxation of imprinted genes in human cancer. Nature 362, 747-749
13. Bliek, J. et al. (2001) Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: Occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS. Hum Mol Genet 10, 467-476
14. DeBaun, M.R. et al. (2002) Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 70, 604-611
15. Sparago, A. et al. (2004) Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. Nat Genet 36, 958-960
16. Prawitt, D. et al. (2005) Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. Proc Natl Acad Sci U S A 102, 4085-4090
17. Niemitz, E.L. et al. (2005) Children with idiopathic hemihypertrophy and beckwith-wiedemann syndrome have different constitutional epigenotypes associated with wilms tumor. Am J Hum Genet 77, 887-891
18. Beckwith, J.B. (1963) Extreme cytomegaly of the adrenal fetal cortex, omphalocele, hyperplasia of kidneys and pancreas, and Leydig-cell hyperplasia: Another syndrome? Proceedings of the Annual Meeting of the Western Society for Pediatric Research, Los Angeles, 11 November 1963 [In: Cohen, M. et al. 1971 The Beckwith-Wiedemann syndrome. Am J Dis Child 122, 515-519]
19. Wiedemann, H.R. (1964) Complexe malformatif familial avec hernie ombilicale et macroglossieun 'syndrome nouveau'? J Genet. Hum. 13, 223-232
20. Weng, E.Y., Moeschler, J.B. and Graham, J.M., Jr. (1995) Longitudinal observations on 15 children with Wiedemann-Beckwith syndrome. Am J Med Genet 56, 366-373
21. Elliott, M. et al. (1994) Clinical features and natural history of Beckwith-Wiedemann syndrome: Presentation of 74 new cases. Clin Genet 46, 168-174
22. Greenwood, R.D. et al. (1977) Cardiovascular abnormalities in the Beckwith-Wiedemann syndrome. Am J Dis Child 131, 293-294
23. Engstrom, W., Lindham, S. and Schofield, P. (1988) Wiedemann-Beckwith syndrome. Eur J Pediatr 147, 450-457
24. Everman, D.B. et al. (2000) Serum alphafetoprotein levels in Beckwith-Wiedemann syndrome. J Pediatr 137, 123-127
25. Borer, J.G. et al. (1999) Renal findings on radiological followup of patients with Beckwith-Wiedemann syndrome. J Urol 161, 235-239
26. Choyke, P.L. et al. (1999) Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 32, 196-200
27. Cole, T.R. and Hughes, H.E. (1994) Sotos syndrome: A study of the diagnostic criteria and natural history. J Med Genet 31, 20-32
28. Tatton-Brown, K. and Rahman, N. (2004) Clinical features of NSD1-positive Sotos syndrome. Clin Dysmorphol 13, 199-204
29. Kurotaki, N. et al. (2002) Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet 30, 365-366
30. Tatton-Brown, K. et al. (2005) Genotypephenotype associations in Sotos syndrome: An analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet 77, 193-204
31. Opitz, J.M., Weaver, D.W. and Reynolds, J.F., Jr. (1998) The syndromes of Sotos and Weaver: Reports and review. Am J Med Genet 79, 294-304
32. Douglas, J. et al. (2003) NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am J Hum Genet 72, 132-143
33. Simpson, J.L. et al. (1975) A previously unrecognized X-linked syndrome of dysmorphia. Birth Defects Orig Artic Ser 11, 18-24
34. DeBaun, M.R., Ess, J. and Saunders, S. (2001) Simpson Golabi Behmel syndrome: Progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition. Mol Genet Metab 72, 279-286
35. Lin, A.E. et al. (1999) Cardiac anomalies in the Simpson-Golabi-Behmel syndrome. Am J Med Genet 83, 378-381
36. Weksberg, R., Squire, J.A. and Templeton, D.M. (1996) Glypicans: A growing trend. Nat Genet 12, 225-227
37. Pilia, G. et al. (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 12, 241-247
38. Li, M. et al. (2001) GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome. Am J Med Genet 102, 161-168
39. Perlman, M. et al. (1973) Renal hamartomas and nephroblastomatosis with fetal gigantism: A familial syndrome. J Pediatr 83, 414-418
40. Piccione, M. et al. (2005) Perlman syndrome: Clinical report and nine-year follow-up. Am J Med Genet A 139, 131-135
41. Henneveld, H.T. et al. (1999) Perlman syndrome: Four additional cases and review. Am J Med Genet 86, 439-446
42. Chernos, J.E., Fowlow, S.B. and Cox, D.M. (1990) A case of Perlman syndrome associated with a cytogenetic abnormality of chromosome 11. Am J Hum Genet 47 Suppl, A28
43. Lee, M.P. et al. (1997) Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat Genet 15, 181-185
44. Reik, W. and Walter, J. (2001) Evolution of imprinting mechanisms: The battle of the sexes begins in the zygote. Nat Genet 27, 255-256
45. Barlow, D.P. (1995) Gametic imprinting in mammals. Science 270, 1610-1613
46. Tilghman, S.M. (1999) The sins of the fathers and mothers: Genomic imprinting in mammalian development. Cell 96, 185-193
47. Matsuoka, S. et al. (1996) Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc Natl Acad Sci U S A 93, 3026-3030
48. Lee, M.H., Reynisdottir, I. and Massague, J. (1995) Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9, 639-649
49. Hatada, I. et al. (1996) An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet 14, 171-173
50. O'Keefe, D. et al. (1997) Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. Am J Hum Genet 61, 295-303
51. Lam, W.W. et al. (1999) Analysis of germline CDKN1C p57KIP2 mutations in familial and sporadic Beckwith-Wiedemann syndrome BWS provides a novel genotype-phenotype correlation. J Med Genet 36, 518-523
52. Bliek, J. et al. (2004) Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome BWS. J Pediatr 145, 796-799
53. Rump, P., Zeegers, M.P. and van Essen, A.J. (2005) Tumor risk in Beckwith-Wiedemann syndrome: A review and meta-analysis. Am J Med Genet A 136, 95-104
54. Lee, M.P. et al. (1997) Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome. Am J Hum Genet 61, 304-309
55. Li, M. et al. (2001) Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations. Genomics 74, 370-376
56. Zhang, P. et al. (1997) Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387, 151-158
57. John, R.M. et al. (2001) Distant cis-elements regulate imprinted expression of the mouse p57Kip2 Cdkn1c gene: Implications for the human disorder, Beckwith-Wiedemann syndrome. Hum Mol Genet 10, 1601-1609
58. Du, M. et al. (2003) Insulator and silencer sequences in the imprinted region of human chromosome 11p15.5. Hum Mol Genet 12, 1927-1939
59. Mannens, M. et al. (1987) Regional localization of DNA probes on the short arm of chromosome 11 using aniridia-Wilms' tumor-associated deletions. Hum Genet 75, 180-187
60. Henry, I. et al. (1993) Somatic mosaicism for partial paternal isodisomy in Wiedemann-Beckwith syndrome: A post-fertilization event. Eur J Hum Genet 1, 19-29
61. Fisher, A.M. et al. (2002) Duplications of chromosome 11p15 of maternal origin result in a phenotype that includes growth retardation. Hum Genet 111, 290-296
62. de Lonlay, P. et al. (1997) Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 100, 802-807
63. Hoyme, H.E. et al. (1998) Isolated hemihyperplasia hemihypertrophy: report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 79, 274-278
64. Wang, Q. et al. (1996) Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12, 17-23
65. Neyroud, N. et al. (1997) A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 15, 186-189
66. Mitsuya, K. et al. (1999) LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids. Hum Mol Genet 8, 1209-1217
67. Smilinich, N.J. et al. (1999) A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. Proc Natl Acad Sci U S A 96, 8064-8069
68. Lee, M.P. et al. (1999) Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Proc Natl Acad Sci U S A 96, 5203-5208
69. Horike, S. et al. (2000) Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith-Wiedemann syndrome. Hum Mol Genet 9, 2075-2083
70. Kanduri, C. et al. (2002) A differentially methylated imprinting control region within the Kcnq1 locus harbors a methylation-sensitive chromatin insulator. J Biol Chem 277, 18106-18110
71. Beatty, L., Weksberg, R. and Sadowski, P.D. (2006) Detailed analysis of the methylation patterns of the KvDMR1 imprinting control region of human chromosome 11. Genomics 87, 46-56
72. Weksberg, R. et al. (2002) Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith-Wiedemann syndrome. Hum Mol Genet 11, 1317-1325
73. Halliday, J. et al. (2004) Beckwith-Wiedemann syndrome and IVF: A case-control study. Am J Hum Genet 75, 526-528
74. Chang, A.S. et al. (2005) Association between Beckwith-Wiedemann syndrome and assisted reproductive technology: A case series of 19 patients. Fertil Steril 83, 349-354
75. Horsthemke, B. and Ludwig, M. (2005) Assisted reproduction: The epigenetic perspective. Hum Reprod Update 11, 473-482
76. Paoloni-Giacobino, A. (2006) Implications of reproductive technologies for birth and developmental outcomes: Imprinting defects and beyond. Expert Rev. Mol. Med. 8
77. Niemitz, E.L. et al. (2004) Microdeletion of LIT1 in familial Beckwith-Wiedemann syndrome. Am J Hum Genet 75, 844-849
78. Hao, Y. et al. (1993) Tumour-suppressor activity of H19 RNA. Nature 365, 764-767
79. Lee, P.D. et al. (1986) Identification of receptors for insulin-like growth factor II in two insulin-like growth factor II producing cell lines. Biochem Biophys Res Commun 134, 595-600
80. Reeve, A.E. et al. (1985) Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 317, 258-260
81. Ogawa, O. et al. (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362, 749-751
82. Weksberg, R. et al. (1993) Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet 5, 143-150
83. Joyce, J.A. et al. (1997) Imprinting of IGF2 and H19: Lack of reciprocity in sporadic Beckwith-Wiedemann syndrome. Hum Mol Genet 6, 1543-1548
84. Sullivan, M.J. et al. (1999) Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation. Oncogene 18, 7527-7534
85. Cui, H. et al. (2002) Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 62, 6442-6446
86. Reik, W. et al. (1995) Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domain. Hum Mol Genet 4, 2379-2385
87. Hori, N. et al. (2002) A dyad oct-binding sequence functions as a maintenance sequence for the unmethylated state within the H19/ Igf2-imprinted control region. J Biol Chem 277, 27960-27967
88. Bell, A.C. and Felsenfeld, G. (2000) Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405, 482-485
89. Hark, A.T. et al. (2000) CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405, 486-489
90. Frevel, M.A. et al. (1999) Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor. J Biol Chem 274, 29331-29340
91. Cui, H. et al. (2001) Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Res 61, 4947-4950
92. Murrell, A., Heeson, S. and Reik, W. (2004) Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat Genet 36, 889-893
93. Takai, D. et al. (2001) Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum Mol Genet 10, 2619-2626
94. Prawitt, D. et al. (2005) Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms' tumor. Nat Genet 37, 785-786; author reply 786-787
95. Sun, F.L. et al. (1997) Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 389, 809-815
96. Sakatani, T. et al. (2001) Epigenetic heterogeneity at imprinted loci in normal populations. Biochem Biophys Res Commun 283, 1124-1130
97. Caspary, T. et al. (1999) Oppositely imprinted genes p57Kip2 and igf2 interact in a mouse model for Beckwith-Wiedemann syndrome. Genes Dev 13, 3115-3124
98. Grandjean, V. et al. (2000) Increased IGF-II protein affects p57kip2 expression in vivo and in vitro: Implications for Beckwith-Wiedemann syndrome. Proc Natl Acad Sci U S A 97, 5279-5284